Ketamine Hydrochloride Injection (PharmaTher)

盐酸氯胺酮注射液 (PharmaTher)

Report date: 2026/04/08 15:41:54

Base Information

Drug NameKetamine Hydrochloride Injection (PharmaTher)
Drug Alias NameKETALS
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeurologic ManifestationsDyskinesiasMovement Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Health Research Institutes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaTher Inc
Active IndicationsN/A
Inactive IndicationsNeurologic ManifestationsDyskinesiasMovement Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksN/A